Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (30690)	10/31/2006 10:37:05 AM
From: Elroy	Read Replies (1) \| Respond to of 57684

and VCLK tomorrow night!

To: Bill Harmond who wrote (30690)	10/31/2006 2:55:16 PM
From: stockman_scott	Respond to of 57684

Hansen Medical Inc., a Mountain View, Calif.-based developer of medical robotics for accurate positioning, manipulation and stable control of catheters, has set its proposed IPO terms to 6.25 million common shares being offered at between $11 and $13 per share. It plans to trade on the Nasdaq under ticker symbol HNSN, with Morgan Stanley and JPMorgan serving as co-lead underwriters. Hansen Medical has raised around $57 million in VC funding since its 2002 inception, from firms like Prospect Venture Partners, Skyline Ventures, Thomas Weisel Healthcare Partners, De Novo Ventures and Vanguard Ventures. hansenmedical.com